Login to Your Account



Refocused E-therapeutics targeting I-O while seeking external validation

By Nuala Moran
Staff Writer

Tuesday, August 8, 2017

LONDON – E-therapeutics plc has completed a corporate reformulation, cutting four of six in-house preclinical projects and now aiming to find partners for candidates generated by its pioneering systems biology drug discovery platform.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription